Research and training are needed so that physicians are able to identify human trafficking victims and refer them to appropriate trauma-informed treatment.

What’s the evidence base for future standards of care for trafficked patients?

AMA Journal of Ethics theme editor Terri Davis, a third-year MD student at West Virginia University School of Medicine, interviewed Ranit Mishori, MD, about how to respond to incidents of suspected human trafficking in health care settings.

Emergency research that requires exception from informed consent presents challenges in defining and reaching the at-risk community.

Public health surveillance for infectious disease provides a model for a mandatory reporting policy for human trafficking, which poses risks for survivors.

Implementation of child abuse reporting laws may help policymakers assess the potential risks and benefits of mandatory reporting of human trafficking.

Bias toward allopathic medicine in the research funding and publication of study results makes it difficult for physicians and others to find accurate data about the efficacy of non-Western, nonallopathic treatments.

Clinical trials for the blood substitute PolyHeme exposed the possibility for ambiguous interpretation of the FDA’s waiver of informed consent for emergency research.

A historical look at dermatological testing and the regulations that have been enacted to protect the patients who test skin care products.